Who has invested in PathoQuest?

SHS Capital, Turenne Capital, SHAM, Kurma Partners, Verve Ventures, Eurazeo are named among the investors backing PathoQuest.

PathoQuest Funding: $15M Raised, Series B (2022)

PathoQuest funding overview

PathoQuest is based in Paris, France. PathoQuest has raised $15M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series B announced in January 2022. The round record for PathoQuest runs through 2022; nothing later has been disclosed. Investors on record include SHS Capital, Turenne Capital, SHAM, Kurma Partners, Verve Ventures, Eurazeo and 2 others. 8 distinct backers are named across the disclosed rounds.

PathoQuest at a glance

Total raised: $15M
Latest round: Series B
Latest round date: January 2022
Headquarters: Paris, France
Notable investors: SHS Capital, Turenne Capital, SHAM, Kurma Partners, Verve Ventures, Eurazeo, Aurinvest, Charles River Laboratories

Frequently asked about PathoQuest funding

How much has PathoQuest raised?: PathoQuest has raised $15M in total disclosed funding across the rounds on record.
Who has invested in PathoQuest?: SHS Capital, Turenne Capital, SHAM, Kurma Partners, Verve Ventures, Eurazeo are named among the investors backing PathoQuest.
What was the latest PathoQuest funding round?: The most recent disclosed round is a Series B, announced in January 2022.
Where is PathoQuest based?: PathoQuest is based in Paris, France.
When did PathoQuest last raise?: The last disclosed PathoQuest round closed in January 2022 at Series B.

We update the PathoQuest record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Paris and their backers are listed below.

PathoQuest Funding: $15M Raised, Series B (2022)

PathoQuest funding overview

PathoQuest at a glance

Frequently asked about PathoQuest funding

Companies related to PathoQuest (19)

Browse related funding lists (8)